An overview of the last year's most important research papers from the field, including discussion of differences between US and European HF guidelines, SGLT2 inhibitor add-on therapies, quadruple therapy in HFmEF/HFpEF, and inequalities in the care of cardiomyopathies.
18-04-2024 | Heart Failure | Video | Article
OFFICIAL VIDEO RECORDING